NCT03351517View on ClinicalTrials.gov

Preemptive Tapentadol on Post-operative Analgesia Following Total Knee Arthroplasty

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

August 20, 2018

Study Completion Date

September 7, 2018

Conditions
Analgesia
Interventions
DRUG

Tapentadol 100 MG

100 mg of oral extended release tapentadol will be given to the patients undergoing total knee replacement surgery on spinal anesthesia to evaluate its efficacy in the management of post-operative pain.

DRUG

Placebo Oral Tablet

A matching placebo will be given to the patients undergoing total knee replacement surgery on spinal anesthesia to evaluate its efficacy in the management of post-operative pain.

Trial Locations (1)

751019

All India Institute of Medical Sciences, Bhubaneswar

All Listed Sponsors
lead

All India Institute of Medical Sciences, Bhubaneswar

OTHER

NCT03351517 - Preemptive Tapentadol on Post-operative Analgesia Following Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter